PerkinElmer completes divestiture of Applied, Food, and Enterprise Services businesses to New Mountain Capital

By The Science Advisory Board staff writers

March 15, 2023 -- PerkinElmer on Monday announced that it has completed its previously announced divestiture of its Applied, Food, and Enterprise Services businesses to New Mountain Capital, a growth-oriented investment firm.

PerkinElmer said that its Life Sciences and Diagnostics business resulting from the divestiture will focus on developing and delivering novel scientific breakthroughs. That business will share the PerkinElmer name with the Applied, Food, and Enterprise Services businesses until a new name, brand, and ticker symbol is unveiled in the second quarter pending shareholder approval.

"As we look ahead, our new Life Sciences and Diagnostics organization has an immense opportunity to continue to lead with science to redefine human health," Prahlad Singh, president and CEO of the PerkinElmer Life Sciences and Diagnostics company, said in a statement.

PerkinElmer launches viral vector assays to boost gene therapy research
PerkinElmer has announced the launch of its "ready-to-use" adeno-associated virus vectors detection kits to support researchers working on gene therapies...
PerkinElmer offers analysis platform for cell and gene therapy research, manufacturing
At the BioProcess International conference in Boston, PerkinElmer launched its new Cellaca PLX Image Cytometry System, which combines image cytometer...
Video from AACC: PerkinElmer on diagnostics, acquisitions
Greg Stock, general manager of PerkinElmer’s Euroimmun business, discussed products and technologies on display at AACC 2022, as well as the integration...
PerkinElmer unveils 3 new RUO library prep kits
PerkinElmer debuted three new research use only (RUO) library preparation kits: Nextflex Small RNA-Seq Kit v4, Nextflex Rapid XP V2 DNA-Seq Kit, and PG-Seq...
PerkinElmer offers automated benchtop solution for NGS library preparation
PerkinElmer has launched an automated benchtop solution for next-generation sequencing (NGS) library preparation of up to eight samples. The research...
PerkinElmer introduces ultrarapid whole-genome sequencing technology
PerkinElmer has launched a novel ultrarapid whole-genome sequencer to improve and accelerate diagnoses in intensive care settings. This ultrarapid whole-genome...
Scitara signs deal with PerkinElmer on IT platform
Scitara is partnering with PerkinElmer on a new scientific integration platform that will grant scientists access to cross-functional data.

Copyright © 2023

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter